About NTxBio
NTxBio is a company based in Santa Fe (United States) founded in 2016 by Alexander Koglin and Michael Humbert.. NTxBio has raised $84.73 million across 10 funding rounds from investors including J P Morgan, Gates Foundation and RA Capital. NTxBio offers products and services including NTxscribe®, NTxpress®, and mRNA Services. NTxBio operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Aqemia, among others.
- Headquarter Santa Fe, United States
- Founders Alexander Koglin, Michael Humbert
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nature's Toolbox, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$84.73 M (USD)
in 10 rounds
-
Latest Funding Round
$9.97 M (USD), Series B
Nov 19, 2025
-
Investors
J P Morgan
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NTxBio
NTxBio offers a comprehensive portfolio of products and services, including NTxscribe®, NTxpress®, and mRNA Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables efficient RNA production using scalable cell-free technology.
Facilitates scalable production of proteins and RNA for therapeutics.
Offers on-demand mRNA production for research and clinical use.
Unlock access to complete
Funding Insights of NTxBio
NTxBio has successfully raised a total of $84.73M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $9.97 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $10.0M
-
First Round
First Round
(15 Aug 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series B - NTxBio | Valuation |
investors |
|
| May, 2025 | Amount | Series B - NTxBio | Valuation |
investors |
|
| Dec, 2024 | Amount | Debt – Venture - NTxBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NTxBio
NTxBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Gates Foundation and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in industrial and life sciences technology companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Comprehensive financial services are provided to corporations and individuals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NTxBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NTxBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ntxbio Comparisons
Competitors of NTxBio
NTxBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Aqemia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ntxbio
Frequently Asked Questions about NTxBio
When was NTxBio founded?
NTxBio was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is NTxBio located?
NTxBio is headquartered in Santa Fe, United States. It is registered at Santa Fe, New Mexico, United States.
Is NTxBio a funded company?
NTxBio is a funded company, having raised a total of $84.73M across 10 funding rounds to date. The company's 1st funding round was a Debt – Venture of $15M, raised on Aug 15, 2018.
What does NTxBio do?
Provider of bio informatics platform to develops biologics and therapeutics. The company offers NTxscribe and NTxpress technologies that enable high-throughput screening and fast prototyping of novel biological materials with defined qualities. NTxscribe delivers high quality, high integrity conventional mRNA and long saRNA compatible for use with modified nucleotides. In addition to cell-free production, NTx offers real-time metabolic profiling of bacteria, fungi, and plants to discover, characterize and ultimately produce new chemical entities (NCEs) and biosimilars.
Who are the top competitors of NTxBio?
NTxBio's top competitors include Helix, Benchling and BioAge Labs.
What products or services does NTxBio offer?
NTxBio offers NTxscribe®, NTxpress®, and mRNA Services.
Who are NTxBio's investors?
NTxBio has 5 investors. Key investors include J P Morgan, Gates Foundation, RA Capital, Anzu Partners, and New Mexico Economic Development Department.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.